PMID: 16634467Apr 26, 2006Paper

Herbal medicine in the treatment of Alzheimer's disease

American Journal of Alzheimer's Disease and Other Dementias
Shahin Akhondzadeh, Seyed Hesameddin Abbasi

Abstract

Alzheimer's disease (AD) is characterized by profound memory loss sufficient to interfere with social and occupational functioning. It is the most common form of dementia, affecting more than 20 million people worldwide. AD is characterized by an insidious loss of memory, associated functional decline, and behavioral disturbances. Patients may live for more than a decade after they are diagnosed with AD, making it the leading cause of disability in the elderly. The incidence of AD ranges from 1 to 4 percent of the population per year, rising from its lowest level at ages 65 to 70 years to rates that may approach 6 percent for those over the age of 85 years. The first neurotransmitter defect discovered in AD involved acetylcholine (ACh). As cholinergic function is required for short-term memory, the cholinergic deficit in AD was also believed to be responsible for much of the short-term memory deficit. Clinical drug trials in patients with AD have focused on drugs that augment levels of ACh in the brain to compensate for the loss of cholinergic function. These drugs have included ACh precursors, muscarinic agonists, nicotinic agonists, and acetylcholinesterase inhibitors. The most highly developed and successful approaches to da...Continue Reading

References

Apr 1, 1976·Archives of Neurology·H LijtmaerR Katzman
Nov 7, 1992·Lancet·J Kleijnen, P Knipschild
Jan 1, 1991·International Clinical Psychopharmacology·I HindmarchH Erzigkeit
Aug 2, 1996·The Journal of Biological Chemistry·D J Selkoe
May 1, 1997·Neurology·D S Geldmacher, P J Whitehouse
Jan 8, 1999·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·A Nordberg, A L Svensson
Jan 12, 1999·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·E K PerryN S Perry
Mar 10, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·P T FrancisG K Wilcock
Jul 20, 1999·The Journal of Pharmacy and Pharmacology·E K PerryN S Perry
Nov 26, 1999·The New England Journal of Medicine·R Mayeux, M Sano
Mar 14, 2000·International Journal of Geriatric Psychiatry·G Livingston, C Katona
Jun 13, 2000·Alzheimer Disease and Associated Disorders·E Giacobini
Feb 2, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Roger Bullock
Jun 14, 2002·Pharmacology, Biochemistry, and Behavior·D O KennedyK A Wesnes
Jun 17, 2003·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Volker Schulz
Nov 2, 2004·Perspectives in Psychiatric Care·Norman L Keltner, Beth Williams

❮ Previous
Next ❯

Citations

Sep 4, 2009·Genes & Nutrition·Lauren Meredith WillisJames A Joseph
Mar 1, 2013·Translational Neurodegeneration·Zhi-Kun SunSheng-Di Chen
Jan 10, 2014·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Seyed Behzad JazayeriMassoud Amanlou
Jul 22, 2014·ISRN Pharmacology·Kennedy K E KukuiaDonatus W Adongo
Dec 21, 2012·Expert Opinion on Investigational Drugs·Meiwan ChenYitao Wang
Mar 5, 2016·Advances in Pharmacological Sciences·Amir R AfshariHamid Mollazadeh
Sep 10, 2009·Evidence-based Complementary and Alternative Medicine : ECAM·Li-Min Fu, Ju-Tzu Li
Jul 24, 2007·Journal of Ethnopharmacology·Xiaoqiang MaPeigen Xiao
Jul 9, 2014·Frontiers in Pharmacology·P MecocciM C Polidori
Oct 19, 2010·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Ganiyu ObohAyodele J Akinyemi
Feb 29, 2008·The American Journal of Chinese Medicine·Fang-Yun SunGuan-Hua Du
May 21, 2016·Bioscience of Microbiota, Food and Health·Yoshiko Miyazaki
Jun 21, 2017·Pharmaceutical Biology·Lucky Legbosi NwiduWayne Grant Carter
Nov 11, 2011·CNS Neuroscience & Therapeutics·Elaine Perry, Melanie-Jayne R Howes
Mar 17, 2018·Journal of Natural Medicines·Anat ElmannOrly Lazarov
Jul 31, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Giovanna Felipe Cavalcante E CostaTales Alexandre Aversi-Ferreira
Jun 7, 2011·Drugs & Aging·Melanie-Jayne R Howes, Elaine Perry
Oct 25, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Eniko ManekGeorg A Petroianu
Mar 4, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Kartik T NakhateDadasaheb M Kokare
Nov 17, 2021·Journal of Biochemical and Molecular Toxicology·Mirali A YavariAbdullah Menzek

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.